Literature DB >> 32031294

Individualized prediction of late-onset dysphagia in head and neck cancer survivors.

Alana Aylward1, Jihye Park2, Sarah Abdelaziz1, Jason P Hunt1, Luke O Buchmann1, Richard B Cannon1, Kerry Rowe3, John Snyder3, Vikrant Deshmukh4, Michael Newman4, Yuan Wan5, Alison Fraser5, Ken Smith5, Shane Lloyd6, Ying Hitchcock6, Mia Hashibe7, Marcus M Monroe1.   

Abstract

BACKGROUND: Limited data exist regarding which head and head and neck cancer (HNC) survivors will suffer from long-term dysphagia.
METHODS: From a population-based cohort of 1901 Utah residents with HNC and ≥3 years follow-up, we determined hazard ratio for dysphagia, aspiration pneumonia, or gastrostomy associated with various risk factors. We tested prediction models with combinations of factors and then assessed discrimination of our final model.
RESULTS: Cancer site in the hypopharynx, advanced tumor classification, chemoradiation, preexisting dysphagia, stroke, dementia, esophagitis, esophageal spasm, esophageal stricture, gastroesophageal reflux, thrush, or chronic obstructive pulmonary disease were associated with increased risk of long-term dysphagia. Our final prediction tool gives personalized risk calculation for diagnosis of dysphagia, aspiration pneumonia, or gastrostomy tube placement at 5, 10, and 15 years after HNC based on 18 factors.
CONCLUSION: We developed a clinically useful risk prediction tool to identify HNC survivors most at risk for dysphagia.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  dysphagia; head and neck cancer; late effects; squamous cell carcinoma; survivorship

Mesh:

Year:  2020        PMID: 32031294     DOI: 10.1002/hed.26039

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Evaluation of Objective and Subjective Swallowing Outcomes in Patients with Dysphagia Treated for Head and Neck Cancer.

Authors:  Hsin-Hao Liou; Shu-Wei Tsai; Miyuki Hsing-Chun Hsieh; Yi-Jen Chen; Jenn-Ren Hsiao; Cheng-Chih Huang; Chun-Yen Ou; Chan-Chi Chang; Wei-Ting Lee; Sen-Tien Tsai; David Shang-Yu Hung
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.